Philip S Macklin - JoVE Visualize

Showing results (11-20 of 15) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 15 results.

European Urology|December 29, 2018

Tumour Seeding in the Tract of Percutaneous Renal Tumour Biopsy: A Report on Seven Cases from a UK Tertiary Referral CentrePhilip S Macklin, Mark E Sullivan, Charles R Tapping, et al.

British Journal of Cancer|October 3, 2019

CM-Path Molecular Diagnostics Forum-consensus statement on the development and implementation of molecular diagnostic tests in the United KingdomPhilip S Macklin, Nischalan Pillay, Jessica L Lee, et al.

The Journal of Clinical Investigation|June 5, 2019

Systemic silencing of PHD2 causes reversible immune regulatory dysfunctionAtsushi Yamamoto, Joanna Hester, Philip S Macklin, et al.

Nature Communications|April 12, 2024

Semmaphorin 3 A causes immune suppression by inducing cytoskeletal paralysis in tumour-specific CD8+ T cellsMike B Barnkob, Yale S Michaels, Violaine André, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 18, 2021

Mitochondrial Inhibitor Atovaquone Increases Tumor Oxygenation and Inhibits Hypoxic Gene Expression in Patients with Non-Small Cell Lung CancerMichael Skwarski, Daniel R McGowan, Elizabeth Belcher, et al.

Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 15 results.

European Urology|December 29, 2018

Tumour Seeding in the Tract of Percutaneous Renal Tumour Biopsy: A Report on Seven Cases from a UK Tertiary Referral CentrePhilip S Macklin, Mark E Sullivan, Charles R Tapping, et al.

British Journal of Cancer|October 3, 2019

CM-Path Molecular Diagnostics Forum-consensus statement on the development and implementation of molecular diagnostic tests in the United KingdomPhilip S Macklin, Nischalan Pillay, Jessica L Lee, et al.

The Journal of Clinical Investigation|June 5, 2019

Systemic silencing of PHD2 causes reversible immune regulatory dysfunctionAtsushi Yamamoto, Joanna Hester, Philip S Macklin, et al.

Nature Communications|April 12, 2024

Semmaphorin 3 A causes immune suppression by inducing cytoskeletal paralysis in tumour-specific CD8+ T cellsMike B Barnkob, Yale S Michaels, Violaine André, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 18, 2021

Mitochondrial Inhibitor Atovaquone Increases Tumor Oxygenation and Inhibits Hypoxic Gene Expression in Patients with Non-Small Cell Lung CancerMichael Skwarski, Daniel R McGowan, Elizabeth Belcher, et al.

Pageof 2